Back to Peptide Pedia
Healing & Recovery
Well Researched

TB-500

TB-500

Synthetic fragment of Thymosin Beta-4.

Also known as: Thymosin Beta-4 fragment

Research dose range2–5 mg weekly (research models)
Route studiedSubcutaneous / intramuscular
Study durationLoading then maintenance studies
Storage2–8 °C reconstituted

Overview

TB-500 is a synthetic version of the active region of Thymosin Beta-4, studied in cell-migration, actin-regulation, and tissue-repair research.

Key research findings

A synthetic fragment spanning the active actin-binding region of Thymosin Beta-4, studied for promoting cell migration, angiogenesis, and tissue repair in recovery models. Its small size and good systemic distribution make it a frequent partner to BPC-157 in repair research.

Mechanism of action

Studied for upregulating actin, promoting cell migration, angiogenesis, and tissue repair in recovery models.

Molecular information

Weight~889 Da (LKKTETQ fragment)
Length7-amino-acid active fragment
TypeThymosin Beta-4 active fragment
Amino-acid sequenceLeu-Lys-Lys-Thr-Glu-Thr-Gln (core actin-binding motif)

TB-500 is the synthetic active region of the 43-residue Thymosin Beta-4 protein.

Pharmacokinetics

Peak: ~1–2 hoursHalf-life: ~2–3 hoursCleared: ~24 hours
Peak · 2hHalf-life · 6h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Tissue-repair research
  • Cell-migration studies
  • Angiogenesis investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Loading referenceAmount: 4–5 mgFrequency: Twice weekly (initial weeks)Route: Subcutaneous
Maintenance referenceAmount: 2–2.5 mgFrequency: Once weeklyRoute: Subcutaneous

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    Early cell-migration and angiogenic responses reported during the loading phase in models.

  2. Week 3–6

    Accelerated tissue repair and remodeling reported in preclinical research.

  3. Maintenance

    Reduced-frequency dosing studied to sustain repair signaling.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

BPC-157

Co-studied together as a tissue-repair stack.

Synergistic

Thymosin Beta-4

TB-500 is a fragment of TB-4 — redundant activity.

Avoid combination

GHK-Cu

Complementary remodeling pathways.

Compatible

Ipamorelin

TB-500 may enhance tissue sensitivity to growth hormone effects

Compatible

CJC-1295 (No DAC)

TB-500 tissue repair combined with GH-releasing effects for comprehensive recovery

Synergistic

IGF-1 LR3

Enhanced muscle and tissue regeneration through complementary growth pathways

Synergistic

Melanotan II

No interaction expected - TB-500 promotes tissue repair via actin regulation, Melanotan Il acts on melanocortin receptors. Completely different receptor families with no pathway overlap.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until fully dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Generally reported as well tolerated in animal models; human safety data are limited.
  • Mild injection-site reactions and transient fatigue are occasionally reported.

References & further reading

Thymosin Beta-4 in tissue repair and regeneration (review)

Preclinicalactin/angiogenesisrepair

Review of Thymosin Beta-4 (and its active fragment) roles in cell migration, angiogenesis, and wound repair.

View study

Topics

healingactinrecovery

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference
Dose range2–5 mg weekly (research models)
RouteSubcutaneous / intramuscular
DurationLoading then maintenance studies
Storage2–8 °C reconstituted
Half-life~2–3 hours
Available at Reviva

TB-500 is stocked as a research-grade compound, ≥99% by HPLC, third-party verified.

View in catalogue